{"id":1225130,"date":[{"year":1999,"month":11,"day":12}],"page":"6","source":"本报","region":"","masthead":"教育新闻","special_issue":"","column":"","genre":"","count":"259","ytitle":"上医大与“吉林通化金马药业”合作","mtitle":"研制治高血压新药","ftitle":"","authors":["钱海虹"],"text":[{"type":"paragraph","text":"本报讯　(通讯员钱海虹)上海医科大学朱依纯教授开发中的治疗高血压的一类新药，将获得吉林通化金马药业股份有限公司的风险投资。"},{"type":"paragraph","text":"上医大与吉林通化金马药业股份有限公司的合作，是首次有企业投资尚在酝酿中的科研成果。公司对此类降压药先期投入150万元的风险基金，并在研制及一期、二期、三期临床实验等过程中逐年进一步投入，总资金为2000万元，用以催化果子尽早成熟。协议规定，该药如果能按照计划或提前获得新药证书，实现产业化后，成果发明人每年还将获得奖励和一定比例的收益。"}]}